Symansis Limited has developed a unique range of products to help you with your cell signaling research.
Our product range includes recombinant human proteins, multi-kinase phospho ELISA arrays and antibodies, inhibitors and immunoassays.
Symansis's product range allows researchers to stimulate pathways to measure activated phospho proteins or to block activity and finally to measure the effects upon biomarker or critical metabolic markers with immunoassays.
Symansis's human cell expressed recombinant proteins closely mimic the natural human protein.
Symansis's proteins and receptors with true glycosylation sites will optimize your research and give you better protein-protein interactions, stability in in vitro and in vivo assays, greater immunogenicity, proteins that are chemically identical to the native protein, and do not contain any xenotypic material, longer half-life and culture, and our bacterial lipolysaccaride free to ensure that they are not cytotoxic.
Our multi-kinase arrays are an alternative analysis platform that allows you to analyze multiple targets at the same time in a single ELISA. That's allowing a whole-picture view of what is going on.
Moreover, this provides researchers with a platform that is easier, faster, more sensitive, more specific, more quantitative, and less expensive than traditional Western blot analysis.
Symansis in conjunction with a world-renowned group of scientists have developed a range of small-molecule inhibitors to assist you with your research.
Symansis has the complete range of PI3 kinase pathway inhibitors and one of the largest selections of small-molecule inhibitors for your cell signaling, cancer, diabetes, ECM, or developmental research.
Symansis inhibitors are manufactured under strict purity and scalability guidelines.
This ensures that we can consistently supply the same high-quality and high-reactivity material time and time again.
Symansis inhibitors have proven quality with a strong and growing publication record that demonstrates it.
More than 90 percent of Symansis's inhibitors are among the most recently disclosed compounds.
More than 80 percent of our inhibitors are in clinical trials.
Finally, Symansis offers inhibitors in several formats, either individually or including premade and custom inhibitor arrays.
Our Easy50 premade array is a 96-well set of 12 cell-signaling inhibitor drugs with seven concentrations of each drug and DMSO control, all designed for ease of use and accuracy.
Stay at the forefront of diabetes research with Symansis's immunoassays.
These ELISA-based assays will help you maximize your diabetes, metabolism, cardiovascular, and obesity research.
Key biomarker and metabolic endpoint targets include insulin, adiponectin, CRP, and FGF-21.
Our assays are highly sensitive, fast, and have tight CV's for great reproducibility.
Our assays are clinical research quality at an affordable price.
For further information on these assays and any of our products, visit symansis.com or contact us at info@symansis.com.
Symansis products are available worldwide, including through our new U.S. warehouse in Temecula, California.
Transcription Services Provided By:
eTranscription Solutions, LLC
www.etranscriptionsolutions.org
(740) 385-5994
CNPG_Symansis-Cell-Signaling-Science-Product-Portfolio